[go: up one dir, main page]

MX9707808A - Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres. - Google Patents

Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.

Info

Publication number
MX9707808A
MX9707808A MX9707808A MX9707808A MX9707808A MX 9707808 A MX9707808 A MX 9707808A MX 9707808 A MX9707808 A MX 9707808A MX 9707808 A MX9707808 A MX 9707808A MX 9707808 A MX9707808 A MX 9707808A
Authority
MX
Mexico
Prior art keywords
chlorophenylcarbamates
chlorophenylthiocarbamates
composition
cancers
growth
Prior art date
Application number
MX9707808A
Other languages
English (en)
Other versions
MXPA97007808A (es
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority claimed from PCT/US1996/004956 external-priority patent/WO1996032104A1/en
Publication of MXPA97007808A publication Critical patent/MXPA97007808A/es
Publication of MX9707808A publication Critical patent/MX9707808A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a una composicion farmacéutica que inhibe el crecimiento de cánceres y de tumores en mamíferos, en particular en humanos y animales de sangre caliente. La composicion también es eficaz contra los virus. La composicion contiene N-clorofenilcarbamatos y N-clorofeniltiocarbamatos que son herbicidas sistématicos. La composicion puede contener N-clorofenilcarbamatos y N-clorofeniltiocarbamatos junto con un agente quimioterapéutico y opcionalmente un potenciador. Se revela también en está solicitud una composicion para tratar infecciones virales en animales o humanos que comprende una cantidad segura u eficaz de N-clorofenilcarbamatos y de N-clorofeniltiocarbamatos y un potenciador.
MX9707808A 1995-08-04 1996-04-11 Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres. MX9707808A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US420913 1995-04-12
US188895P 1995-08-04 1995-08-04
US001888 1995-08-04
PCT/US1996/004956 WO1996032104A1 (en) 1995-04-12 1996-04-11 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers

Publications (2)

Publication Number Publication Date
MXPA97007808A MXPA97007808A (es) 1998-01-01
MX9707808A true MX9707808A (es) 1998-01-31

Family

ID=39165653

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707808A MX9707808A (es) 1995-08-04 1996-04-11 Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.

Country Status (2)

Country Link
US (1) US20010041678A1 (es)
MX (1) MX9707808A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6423734B1 (en) * 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections

Also Published As

Publication number Publication date
US20010041678A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
CA2217953A1 (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
HUP9903420A3 (en) Use of fluconazole for the preparation of pharmaceutical compositions, inhibiting the growth of cancers and treating viral infections
EP1128832A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
TR199701150T1 (xx) Memeli canl�larda vir�slerin ve kanserlerin geli�mesini �nlemeye mahsus, N-klorofenil karbamatlar�, N-klorofeniltiokarbamatlar� ve N-fosfonoglisin t�revlerini i�eren bir farmas�tik bile�im.
IL118426A (en) Pharmaceutical composition containing 1,3- bis-triazolyl-2-propanol derivative for treating cancer tumors or viruses
CA2281570A1 (en) Composition for treating tumors containing shark cartilage extracts and anti-neoplastic agents
AR002987A1 (es) Composicion farmaceutica para el tratamiento de infecciones virales ocanceres o tumores, composicion de dosis unitaria que la comprende y uso para dicho tratamiento
MX9800944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibir el crecimiento de canceres.
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
MX9707808A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos y n-clorofiniltiocarbamatos para inhibir el crecimiento de virus y canceres.
FI961380A7 (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitam iseksi
GB2166050B (en) 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans
FI965114A7 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
HUP9802536A3 (en) Pharmaceutical compositions containing 1,2,4-benzotriazine 1,4-dioxide and use thereof for the preparation of pharmaceutical compositions treating cancer
MX9707810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimiento de virus y canceres.
BR9812002A (pt) Compostos com efeito antiprimeiro-passe
MX9707811A (es) Una composicion farmaceutica que contiene n-clorofenilcarbamatos, n-clorofeniltiocarbamatos y derivados de n-fosfonoglicina para inhibir el crecimiento de canceres y virus en mamiferos.
TR199901998T2 (xx) 9,10-sekokolesta-5,7,10(19)-triyen-1,3-diyol veya alfakasidol�n kullan�m�.
MX9709530A (es) Uso de bis-1,2.4-triazoles para la manufactura de un medicamento para el tratamiento de canceres.
CA2259997A1 (en) Remedies and preventives for stomatitis
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: THE UNIVERSITY OF ARIZONA FOUNDATION

FA Abandonment or withdrawal